Healthcare

Global Biomarker Market Size study, by Disease Indication (Cancer, Cardiovascular Disorder, Infectious Diseases, Neurological Disorder, Immunological Disorder, Others), by Application (Diagnosis, Drug Discovery and Development, Others), by End-Use (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Laboratories), by Product Type (Biomarker Test Kits, Biomarker Analyzers) and Regional Forecasts 2018-2025

  • BIZ2954220
  • 200 Pages
  • February 2019
  • Healthcare
Download Sample    Get Discount   
 
Global Biomarker Market to reach USD XX billion by 2025.

Global Biomarker Market valued approximately USD 29.5 billion in 2017 is anticipated to grow with a healthy growth rate of more than 13% over the forecast period 2018-2025. The Biomarker Market is continuously growing in across the world over the upcoming years. Biomarker is a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures and biological procedures. It is also known as signature molecule or molecular marker. Increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries are the substantial driving factors of the market across the world. Furthermore, growing demand from emerging economies is creating numerous opportunity in the market over the upcoming years. Biomarkers are used to assist medical professionals to take effective clinical decisions and it also helps in diagnosing the health of patients. Also, biomarkers are predicting drug efficacy quickly than conventional clinical endpoints. These benefits of Biomarker also increasing demand among its end-user industries over the upcoming years. However, high capital investments and low cost-benefit ratio, poorly suited regulatory and reimbursement systems, and technical issues related to sample collection and storage is the restraining factors of the market across the globe.

The regional analysis of Global Biomarker Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region in the global Biomarker market due to growing prevalence of cancer and increasing adoption of precision medicine in the region. Europe is also estimated to grow in the global Biomarker market over the forecasted period 2018-2025. However, Asia-Pacific is also witnessed to grow at higher rate over the forecasted period 2018-2025.

The major market player included in this report are:

• Abbott Laboratories

• Medtronic

• BG Medicine Inc.

• Hoffmann LA Roche Ltd.

• Siemens Healthnineers

• Nexus-DX

• Qiagen N.V.

• Lifesign LLC

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Indication:

? Cancer, Cardiovascular Disorder

? Infectious Diseases

? Neurological Disorder

? Immunological Disorder

? Others

By Application:

? Diagnosis

? Drug Discovery and Development

? Others

By End-Use:

? Hospitals

? Research Laboratories

? Ambulatory Surgical Centers

? Diagnostic Laboratories

By Product Type:

? Biomarker Test Kits

? Biomarker Analyzers

By Regions:

? North America

o U.S.

o Canada

? Europe

o UK

o Germany

? Asia Pacific

o China

o India

o Japan

? Latin America

o Brazil

o Mexico

? Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016

Base year – 2017

Forecast period – 2018 to 2025

Target Audience of the Global Biomarker Market in Market Study:

? Key Consulting Companies & Advisors

? Large, medium-sized, and small enterprises

? Venture capitalists

? Value-Added Resellers (VARs)

? Third-party knowledge providers

? Investment bankers

? Investors

TABLE OF CONTENTS

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Key Trends

1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)

1.3.1. Biomarker Market, by Disease Indication, 2015-2025 (USD Billion)

1.3.2. Biomarker Market, by Application, 2015-2025 (USD Billion)

1.3.3. Biomarker Market, by End-Use, 2015-2025 (USD Billion)

1.3.4. Biomarker Market, by Product Type, 2015-2025 (USD Billion)

1.3.5. Biomarker Market, by Region, 2015-2025 (USD Billion)

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Biomarker Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Industry Evolution

2.2.2. Scope of the Study

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Biomarker Market Dynamics

3.1. See Saw Analysis

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Biomarker Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Buyers

4.1.2. Bargaining Power of Suppliers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model

4.2. PEST Analysis

4.2.1. Political Scenario

4.2.2. Economic Scenario

4.2.3. Social Scenario

4.2.4. Technological Scenario

4.3. Value Chain Analysis

4.3.1. Supplier

4.3.2. Manufacturers/Service Provider

4.3.3. Distributors

4.3.4. End-Uses

4.4. Key Buying Criteria

4.5. Regulatory Framework

4.6. Cost Structure Analysis

4.6.1. Raw Material Cost Analysis

4.6.2. Manufacturing Cost Analysis

4.6.3. Labour Cost Analysis

4.7. Investment Vs Adoption Scenario

4.8. Analyst Recommendation & Conclusion

Chapter 5. Biomarker Market, by Disease Indication

5.1. Market Snapshot

5.2. Market Performance - Potential Model

5.3. Key Market Players

5.4. Biomarker Market, Sub Segment Analysis

5.4.1. Cancer

5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.4.2. Cardiovascular Disorder

5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.4.3. Infectious Disease

5.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.4.4. Neurological Disorder

5.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.4.5. Immunological Disorder

5.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.4.6. Others

5.4.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.4.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Biomarker Market, by Application

6.1. Market Snapshot

6.2. Market Performance - Potential Model

6.3. Key Market Players

6.4. Biomarker Market, Sub Segment Analysis

6.4.1. Diagnosis

6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.2. Drug Discovery and Development

6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.4.3. Others

6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. Biomarker Market, by End-Use

7.1. Market Snapshot

7.2. Market Performance - Potential Model

7.3. Key Market Players

7.4. Biomarker Market, Sub Segment Analysis

7.4.1. Hospitals

7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.2. Research Laboratories

7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.3. Ambulatory Surgical Centers

7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.4.4. Diagnostic Laboratories

7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Biomarker Market, by Product Type

8.1. Market Snapshot

8.2. Market Performance - Potential Model

8.3. Key Market Players

8.4. Biomarker Market, Sub Segment Analysis

8.4.1. Biomarker Test Kits

8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2. Biomarker Analyzers

8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 9. Biomarker Market, by Regional Analysis

9.1. Biomarker Market, Regional Market Snapshot (2015-2025)

9.2. North America Biomarker Market Snapshot

9.2.1. U.S.

9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.2.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.2.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.2.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.2.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.2.2. Canada

9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.2.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.2.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.2.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.2.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3. Europe Biomarker Market Snapshot

9.3.1. U.K.

9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.3.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.1.6.

9.3.2. Germany

9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.3.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.3. France

9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.3.3.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.3.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.3.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.4. Rest of Europe

9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.3.4.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.4.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.4.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4. Asia Biomarker Market Snapshot

9.4.1. China

9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.4.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.2. India

9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.4.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.3. Japan

9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.4.3.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.3.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.3.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.4. Rest of Asia Pacific

9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.4.4.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.4.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.4.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.5. Latin America Biomarker Market Snapshot

9.5.1. Brazil

9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.5.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.5.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.5.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.5.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.5.2. Mexico

9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.5.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.5.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.5.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.5.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.6. Rest of The World

9.6.1. South America

9.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.6.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.6.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.6.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.6.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.6.2. Middle East and Africa

9.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.6.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.6.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.6.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.6.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 10. Competitive Intelligence

10.1. Company Market Share (Subject to Data Availability)

10.2. Top Market Strategies

10.3. Company Profiles

10.3.1. Abbott Laboratories

10.3.1.1. Overview

10.3.1.2. Financial (Subject to Data Availability)

10.3.1.3. Summary

10.3.1.4. Recent Developments

10.3.2. Medtronic

10.3.3. BG Medicine Inc.

10.3.4. Hoffmann LA Roche Ltd.

10.3.5. Siemens Healthnineers

10.3.6. Nexus-DX

10.3.7. Qiagen N.V.

10.3.8. Lifesign LLC

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.1.6. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF BIOMARKER MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF BIOMARKER MARKET

TABLE 3. BIOMARKER MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. BIOMARKER MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)

TABLE 7. BIOMARKER MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)

TABLE 8. BIOMARKER MARKET ESTIMATES & FORECASTS BY Disease Indication 2015-2025 (USD BILLION)

TABLE 9. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 10. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 11. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 12. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 13. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 14. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 15. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 16. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 17. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 18. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 19. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 20. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 21. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 22. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 23. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 24. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 25. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 26. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 27. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 28. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 29. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 30. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 31. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 32. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 33. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 34. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 35. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 36. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 37. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 38. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 39. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 40. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 41. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 42. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 43. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 44. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 45. U.S. BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 46. U.S. BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 47. U.S. BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 48. U.S. BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 49. U.S. BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 50. CANADA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 51. CANADA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 52. CANADA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 53. CANADA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 54. CANADA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 55. UK BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 56. UK BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 57. UK BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 58. UK BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 59. UK BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 60. GERMANY BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 61. GERMANY BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 62. GERMANY BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 63. GERMANY BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 64. GERMANY BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 65. ROE BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 66. ROE BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 67. ROE BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 68. ROE BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 69. ROE BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 70. CHINA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 71. CHINA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 72. CHINA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 73. CHINA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 74. CHINA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 75. INDIA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 76. INDIA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 77. INDIA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 78. INDIA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 79. INDIA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 80. JAPAN BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 81. JAPAN BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 82. JAPAN BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 83. JAPAN BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 84. JAPAN BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 85. ROAPAC BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 86. ROAPAC BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 87. ROAPAC BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 88. ROAPAC BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 89. ROAPAC BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 90. BRAZIL BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 91. BRAZIL BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 92. BRAZIL BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 93. BRAZIL BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 94. BRAZIL BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 95. MEXICO BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 96. MEXICO BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 97. MEXICO BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 98. MEXICO BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 99. MEXICO BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 100. ROLA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 101. ROLA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 102. ROLA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 103. ROLA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 104. ROLA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 105. ROW BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)

TABLE 106. ROW BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 107. ROW BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 108. ROW BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

TABLE 109. ROW BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370